» Articles » PMID: 32807688

Repeated COVID-19 Relapse During Post-discharge Surveillance with Viral Shedding Lasting for 67 Days in a Recovered Patient Infected with SARS-CoV-2

Overview
Date 2020 Aug 19
PMID 32807688
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.

Citing Articles

A Systematic Review of Chest Imaging Findings in Long COVID Patients.

Bazdar S, Kwee A, Houweling L, de Wit-van Wijck Y, Mohamed Hoesein F, Downward G J Pers Med. 2023; 13(2).

PMID: 36836515 PMC: 9965323. DOI: 10.3390/jpm13020282.


Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.

Toro-Huamanchumo C, Hilario-Gomez M, Pinedo-Castillo L, Zumaran-Nunez C, Espinoza-Gonzales F, Caballero-Alvarado J New Microbes New Infect. 2022; 48:101021.

PMID: 36060548 PMC: 9420201. DOI: 10.1016/j.nmni.2022.101021.


Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.

Koupaei M, Mohamadi M, Yashmi I, Shahabi A, Shabani A, Heidary M J Clin Lab Anal. 2022; 36(5):e24402.

PMID: 35396748 PMC: 9102618. DOI: 10.1002/jcla.24402.


Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.

Tang X, Musa S, Zhao S, He D Front Public Health. 2021; 9:663045.

PMID: 34178920 PMC: 8226004. DOI: 10.3389/fpubh.2021.663045.


Distribution of SARS-CoV-2 RNA signal in a home with COVID-19 positive occupants.

Maestre J, Jarma D, Yu J, Siegel J, Horner S, Kinney K Sci Total Environ. 2021; 778:146201.

PMID: 34030356 PMC: 7942153. DOI: 10.1016/j.scitotenv.2021.146201.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Yao X, He Z, Li T, Zhang H, Wang Y, Mou H . Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Res. 2020; 30(6):541-543. PMC: 7186763. DOI: 10.1038/s41422-020-0318-5. View

3.
Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K . Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis. 2020; 95:183-191. PMC: 7193136. DOI: 10.1016/j.ijid.2020.03.013. View

4.
Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F . Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. Euro Surveill. 2020; 25(10). PMC: 7078824. DOI: 10.2807/1560-7917.ES.2020.25.10.2000191. View

5.
Lan L, Xu D, Ye G, Xia C, Wang S, Li Y . Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020; 323(15):1502-1503. PMC: 7047852. DOI: 10.1001/jama.2020.2783. View